跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,905 条关于
“KRAS-mutant CRC”
全部
5,905
临床试验
3,706
药物
682
机构
42
资讯
1,475
13年前
Resminostat Shows Promise in Advanced Cancers: Clinical Updates and Biomarker Identification
去年
Breakthrough in Colorectal Cancer Drug Discovery: Novel Nano-Delivery Systems and Precision Therapy Targets Identified
4天前
FDA Grants Fast Track Designation to Kestrel's Oral Pan-KRAS Inhibitor KST-6051 for KRAS-Mutant Solid Tumors
去年
Amgen Develops Pan-KRAS Inhibitor AMG 410 to Target Broader Range of KRAS-Mutant Tumors
去年
InxMed Reports Breakthrough Results for Ifebemtinib-Garsorasib Combination in KRAS G12C-Mutant Cancers at ASCO 2025
去年
RMC-9805 Demonstrates Promising Activity in KRAS G12D-Mutated Pancreatic Cancer
去年
Verastem's Avutometinib and Defactinib Combination Receives FDA Priority Review for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
9个月前
Pelareorep Shows 33% Response Rate in KRAS-Mutant Colorectal Cancer, Tripling Standard-of-Care Outcomes
去年
KRAS G12C Mutations Associated with Shorter Survival in First-Line Metastatic Colorectal Cancer Treatment
去年
Revolution Medicines Reports Promising Results for Zoldonrasib in KRAS G12D Mutant Lung Cancer
第 1 页,共 148 页
上一页
下一页